ShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market
SHANGHAI, June 19, 2017 /PRNewswire/ -- ShangPharma, a leading life science partnering organization providing high-quality and cost-effective drug development and discovery services, technology, and investment for the pharmaceutical and biotechnology industry, announced today the intent to ...
ShangPharma Innovation Names Founding Executive-In-Residence Team
SOUTH SAN FRANCISCO, California, June 2, 2017 /PRNewswire/ -- ShangPharma Innovation (SPI) announced the appointment ofPeter DiLaura, Ravi Kiron MBA PhD, Krishna Kodukula PhD, and Robert Wild PhD to its founding Executive-In-Residence (EIR) team. The EIR team will provide ShangPharma Innovation ...